Figure 2. Meta-analyses of case-control studies between serum CRP levels and schizophrenia.
The results of the meta-analysis of fifteen case-control studies which measured serum CRP levels (N = 4,734). The serum CRP levels were significantly higher in patients with schizophrenia than in the controls (SMD = 0.62; 95% CI, 0.24–0.99; p = 1.4 × 10−3 in the random-effects model).